摘要
目的观察胰酶肠溶胶囊治疗酒精性脂肪肝合并消化不良的临床疗效。方法选取我院收治的酒精性脂肪肝合并消化不良患者106例,随机分组,各53例。对照组采取多烯磷脂酰胆碱治疗,观察组在对照组基础上加用胰酶肠溶胶囊治疗,两组均治疗4周,对比两组临床疗效及不良反应发生情况。结果观察组总有效率(94.3%)显著高于对照组(71.7%),差异有统计学意义(P<0.05);两组不良反应对比差异无统计学意义(P>0.05)。结论胰酶肠溶胶囊治疗酒精性脂肪肝合并消化不良患者,可显著提高临床疗效。
Objective To observe the clinical effect of Pancreatin Enteric-coated Capsules in treatment of alcoholic fatty liver combined with dyspepsia.Methods106 cases of alcoholic fatty liver combined with dyspepsia in our hospital were selected, randomly grouping, each of 53 cases. Control group was treated with Polyene Phosphatidyl choline, and the observation group was treated with Pancreatin Enteric-coated Capsules based on treatment of control group. The two groups were all treated for four weeks, and the clinical efifcacy and adverse reactions of the two groups were compared.ResultsThe total effective rate of the observation group （94.3%） was signiifcantly higher than that of the control group （71.7%）, and the difference was statistically signiifcant （P〈0.05）; There was no signiifcant difference in adverse reactions between the two groups （P〉0.05）. Conclusion Pancreatin Enteric-coated Capsules treatment of alcoholic fatty liver in patients with dyspepsia, can signiifcantly improve the clinical efifcacy.
出处
《中国继续医学教育》
2016年第24期142-143,共2页
China Continuing Medical Education
关键词
酒精性脂肪肝
消化不良
胰酶肠溶胶囊
Alcoholic fatty liver
Dyspepsia
Pancreatin Enteric-coated Capsules
